Online Submissions

Already have a Username/Password for Anaesthesiology Intensive Therapy?

Go to Login

Need a Username/Password?

Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

Author Guidelines


Journal follows editorial recommendations of International Committee of Medical Journal Editors (ICMJE) (available at

Via Medica strongly recommends journal editors to adhere to the principles of Committee on Publication Ethics (COPE), particularly to deal with acts of ethical misconduct. For more information Authors, Readers and Editors may visit the COPE website:


‘Anaesthesiology Intensive Therapy’ is the official journal of the Polish Society of Anaesthesiology and Intensive Therapy, and has been published since 1969.

‘Anaesthesiology Intensive Therapy’ is published five times a year and is addressed chiefly to anaesthesiologists. However, due to the wide range of subjects it tackles (i.e. issues associated with anaesthesia, intensive therapy, resuscitation, pain research and management, emergency medical care, and perioperative medicine) and the interdisciplinary character of its articles, it is also aimed at physicians with other specialisms.

The journal is indexed in MEDLINE (PubMed), Elsevier Bibliographic Database, Ministry of Science and Higher Education, Index Copernicus and the Polish Medical Bibliography.

Papers submitted should conform to standards set out in the Declaration of Helsinki (

On the basis of the Declaration of Helsinki, Anaesthesiology Intensive Therapy requires that all manuscripts reporting clinical research state in the first paragraph of the Methods section that:

1. The study was approved by the appropriate  Ethical Review Board (with full name of this committee);

2. Written informed consent was obtained from all subjects, a legal surrogate, or the parents or legal guardians for under age subjects, or that the requirement for written informed consent was waived by the ethics committee.

Lack of such statements may result in the rejection of a manuscript without review process.

Authors should avoid the use of any data that might lead to the identification of patients, or violate their rights or doctor/patient confidentiality. In the case of animal studies, their design is additionally assessed by the editorial board, which reserves the right to reject a paper if a study has involved the infliction of unnecessary suffering on animals or has led to their permanent disability.

Potential conflict of interests. Authors should submit statements of their potential connections with the medical or pharmaceutical industries and any possible conflict of interests concerning the paper’s subject matter. Such information is confidential and its potential disclosure is agreed with authors prior to the article’s publication. Papers sponsored by companies directly interested in publication should be clearly marked.

Ghostwriting and guest-authorship are forbidden. When we detect ghost written manuscripts, action will be taken against both the submitting authors and other participants.

Statements. Each manuscript should be accompanied by the following documents: a) approval of hospital or departmental authorities where the study was conducted; and b) an author’s statement that the paper has not been published in whole or in part in any other journal. Such a statement means that copyright becomes vested in the Polish Society of Anaesthesiology and Intensive Therapy, and permission to republish must be obtained from the Society. Tables and figures taken from other publications require additional consent for reproduction from their authors and/or publishers.

Rules for acceptance of papers for publication

The Journal accepts for publication papers in Polish and English. Submitted articles are reviewed by experts in the field of anaesthesiology and intensive therapy, and, if necessary, in other specialisms. Papers are reviewed following a preliminary assessment carried out by the Editor concerning their compliance with the above-mentioned standards. If there are any reservations, papers are returned to the authors with suggestions as to final corrections. Papers accepted for publication are published in the following sections:

1. Editorials

2. Original and Clinical Articles

3. Review Articles

4. Miscellanea

5. Correspondence.


One printed hard copy of the manuscript should be submitted, together with a disc (MS Word Editor) containing the whole of the material to be published. Our preferred font is Times New Roman, 12 point. Guidelines concerning the text’s formatting should be indicated on the margin of the printout. Papers may also be submitted via e-mail and appropriate statements by the traditional postal system. Articles should not exceed: 12 pages (original and clinical articles), or 16 pages (review articles). Text should be double-spaced with margins (approx. 1,800 characters per page).

Vocabulary. Neologisms of English origin should be avoided. All foreign language words (including explanations of abbreviations) should be italicised. Jargon expressions should be replaced with commonly understood phrases. Letters of the Greek alphabet should be used in the original form.

Papers that do not comply with the aforesaid requirements will be returned to the contributors without revision. The Editor reserves the right to correct mistakes in style and medical nomenclature and to shorten the text without consulting the author.


Title page. There should be a separate title page, including the title of the paper, the name(s) of the author(s), the name of the institution where the study was carried out, short running title and address(es) for correspondence. The title of the paper in Polish should be a concise description of the study. Below there should be a translation of the title into English. In subsequent paragraphs there should appear the names and surnames of authors (without titles), followed by the name of the institution where the paper was prepared. When authors come from different institutions, this should be marked with appropriate notes in Arabic numerals appearing in the text in superscript. The name of the institution where the work was carried out should not be excessively elaborate and should not include the name of its patron, if it has one. The short running title should be limited to 2–3 words. Key words, of 1-5 sets, should be laid out in two stages, i.e.: main issue followed by detailed reference (acc. to Green NM: Key words in anaesthesiology, Elsevier, 1988).


Desflurane for obstetric anaesthesia

Jan Kowalski1 Adam Jaworski2

1Department of Anaesthesiology and Intensive Therapy in X

2Department of Clinical Pharmacology in Y

Key words: anaesthesia, obstetric; volatile anaesthetics, desflurane

Short running title: Desflurane in obstetricsAddress for correspondence should include name and surname of the author to whom the correspondence is to be addressed, exact postal address, telephone and fax numbers, and e-mail address.

Abstract. Abstracts should be in English and divided into: Background, Methods, Results, Conclusion (for original and clinical articles), whereas for review articles should have a descriptive character. The abstract should be brief (250 words) and refer to the content of the paper. It is to be published unchanged in the MEDLINE Bibliographic Database.

Introduction. Introduction does not require subtitle and includes work assumptions against the background of existing knowledge. In the case of continuation of earlier studies, it is recommended that authors` previous publications be quoted. Its final part should clearly specify the aim of the study.

Methods. Methods should be described in such a way as to allow verification and possible repetition of the study. When previously published methods are used, their description is necessary only if they were considerably modified, otherwise an appropriate citation is sufficient. Detailed discussion of such commonly known methods as epidural analgesia or basic haemodynamic measurements is not necessary. In cases when medical equipment and devices are not used as research tools, or when their usage has not significantly influenced the obtained results, there is no need for their detailed description; otherwise, their names should be given followed by the manufacturer’s name and the country of origin in brackets, e.g.: ‘patients` lungs were ventilated with the Evita respirator (Drager, Germany)’. Proper names of medicines and agents should be given in their pharmacopeial and not proprietary form, using terminology included in the publication: Podlewski JK, Chwalibogowska Podlewska A: Leki współczesnej terapii, PZWL, Warsaw, latest edition.

In cases of comparative evaluation of medicines, or if their use may affect the study’s final results, its trade name, manufacturer and country of origin should be specified in brackets, for example: propofol (Diprivan, AstraZeneca, USA). Proprietary names should be given without the registered trademark symbol. This part should also contain information concerning the statistical analysis of the findings that was employed and the assumed confidence interval. Please do not use the phrase: ‘analysis was carried out using the Statistica programme’ or such like. The decision concerning the type of analysis should have been made already during the preparation stage. Wrong choice of the type of analysis will result in the paper’s rejection.

Results. Results should be presented in a clear and understandable manner, and should not go beyond the scope set out in the methods. Data from tables and figures should not be repeated unnecessarily in the text, but only described, e.g.: ‘blood pressure decreased considerably after nitroglycerine (Tab. 3)’. Results should be accompanied by credible mathematical analysis, annotated with appropriate statistical symbols.

Discussion. Discussion should interpret the obtained results (and not repeat them) against the background of existing knowledge, taken from cited references. It should not assume the character of a review article, i.e. comment on references without relating to the author’s findings. Cited references concerning an individual issue, should not exceed the four most important items. Names of authors of other publications should not be cited too often; it is the achievements that are of real importance. An exception to this rule is made for outstanding, innovative papers of considerable significance. Numbers of references should appear in the text in square brackets at the end of a sentence. Citing the name of an author of another publication entails placing the reference item number immediately after the name.

Conclusions. Conclusions should concern the aim of the study, and should directly relate to the study results. They should be presented in the form of single, simple sentences, revealing a concrete thought. This part should generalise the presented results and not repeat them.

Acknowledgement relating to this article. The acknowledgements section should obtain the following distincts statements in separate paragraphs:

1. Assistance with the article. Acknowledgements should be made only to those who have made a substantial contribution to the study. Authors are responsible for obtaining written permission from people acknowledged by name in case readers infer their endorsement of data and conclusions. If there was no assistance state: none.

2. Financial support and sponsorship. You must make reference to all relevant sources of funding concerning this article. If there were no sources of funding please state: none.

3. Conflicts of interest. You must make reference to all relevant conflicts of interest concerning this article. If there are no conflicts of interest please state: none.

4. Presentation (for original articles only). Presentations of preliminary data at, for example, international meetings should be acknowledged separately. If preliminary data was not previously presented please state: none.


Acknowledgements relating to this article: We would like to thank Dr. Ewa Nowak  for her assistance with the study.

Financial support and sponsorship: This work was supported by the Department of Anaesthesiology, London Hospital, London, UK.

Conflicts of interest: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organisation Y, and C is on the speaker’s bureau for Organisation X. For the remaining authors none were declared.

Presentation: Preliminary data for this study were presented as a poster presentation at the International Congress of the Polish Society of Anaesthesiology and Intensive Therapy, Wisla 14-18 September 2014.

References. References should not exceed 20 items in the case of original and clinical articles, and 50 items for review articles. The recommended style for references is of Index Medicus/NLM:( Reference items should be put in a list according to the order in which they are cited in the text. Each item should contain the following: a) surnames and first letters of names (without a dot) of all the authors; b) full title of the paper in original (capital letters should not be used at the beginning of each word, only the first word should begin with a capital letter); c) abbreviated name of the journal in which the paper was printed in the form specified by Index Medicus; and d) year of publication, volume, full numbers of the first and last pages of the cited passage; e.g.:

Comber X, Dhonneur G, McElwain J, Malik MA, Laffey JG. Difficult tracheal intubation. Br J Anaesth 2010, 104: 260–261.

With respect to book publications, the following should be specified: a) surname and the first letter of the author’s name (in the case of joint publications, only the name of the three authors should be given and followed by ‘and colleagues’); b) title of the book; c) publisher; d) place of publication; and e) year of publication and full numbers of the first and last pages of the cited passage. When citation concerns a book chapter, the following should be included: a) surname and the first letter of the author’s name; b) chapter’s title, preceded by ‘in:’; c) book’s title (in brackets); d) Ed: book editor’s surname; the rest as in the case of a book publication, e.g.:

Brunkhorst FM: Avoiding harm in metabolic management. In: Chiche J-D, Moreno R, Rhodes A (ed.): Patient safety and quality of care in intensive care medicine. Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin 2009: 341–348.

Internet papers from acknowledged and reviewed websites are also admissible. These should contain the following: a) surname and first letter of the author’s name; b) paper’s title; and c) URL address, e.g.: Shanahan D: Anatomy for anaesthetists. The virtual anaesthesia textbook, Numbered items of references should begin with a new paragraph. Spelling mistakes should be avoided and attention should be paid to proper punctuation, as shown in the above examples. The Editor reserves the right to delete not credible and wrongly cited references, as well as their context.

Note: In literature references, authors are obliged to present the DOI numbering for the articles with the numbers.

Units. Units should be given in accordance with the International System of Units (SI). In the cases of measurements of airway pressure, gasometric analyses, and others in which mm Hg or cm H2O are used, both units should be included, e.g.: airway pressure was 20 cmH2O (0.2 kPa). This does not apply to the value of blood pressure, which is given only in mm Hg. In all other cases (and this concerns particularly the results of biochemical and haemodynamic studies) SI is the only acceptable system.

Symbols and abbreviations. Symbols and abbreviations should be explained in brackets in their full form the first time they appear in the text. This rule does not apply to well-known and commonly used words and phrases such as: FRC, SIMV, IPPV, EKG, INR, HR, SAP/DAP, SpO2, FIO2, EtCO2, EEG, VAS, TISS, CT, RTG, DIC, AST, ASA, Hb, Ht, N2O, O2, Ca2+,or K+. It is obligatory to explain acronyms which are not well known, e.g.: ‘ILV, Independent Lung Ventilation’.

Figures. All figures should be submitted in one copy printed on separate sheets as well as on disc, as an original file, together with the name of the program used for their preparation. The recommended format for figures is: tif, cdr, jpeg. Low resolution materials as well as figures in MS Word editor are not accepted. Moreover, the Editor will admit scanned materials provided that their quality is satisfactory. It is recommended that the figures are of the same size, clear, numerated (Arabic numbers) and described in detail; in the case of photographs — on the reverse. The photographs cannot in any way allow identification of a patient or breach his or her rights in any other way; otherwise, a written consent for publication is required. A separate sheet should contain a list of all figure titles, with an explanation of any symbols used.

Tables. All tables should be prepared and submitted similarly to figures. They should not be placed in the text. The table’s number (Arabic) and title should be given above, whereas explanations of symbols and abbreviations should follow the table. If possible, inside the table no lines dividing columns and rows should be used. Names of tested parameters should be accompanied by units in which the results are presented, e.g.: creatinine (umol L-1). The Editor reserves the right to edit tables or remove parts of data from them. Should the same data be presented in both figures and tables, the Editor will choose only one of these.


All collaborators who have made significant and substantial contributions to a study are considered to be coauthors. The nature and level of contribution of all authors of accepted manuscripts must be indicated, i.e. conception, design, execution and interpretation of the data being published, and who has written  the paper. An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Other contributions to the work, such as providing reagents or analytic tools, should be listed in the Acknowledgements. Ghostwriting and guest-authorship are forbidden. When we detect ghost written manuscripts, action will be taken against both the submitting authors and other participants.


The opinions and information published in ‘Anaesthesiology Intensive Therapy’ do not necessarily represent the views of the Editor or the Publisher, who cannot be held responsible for any consequences of their publication. Promotional materials are printed in the journal at the request of sponsors, and should not be perceived as representing the Editor’s or the Publisher’s opinions with respect to its contents.

Manuscripts are submitted electronically using the Electronic Manuscript Submission panel available on the website

Corresponding address:

Prof. Radosław Owczuk

Klinika Anestezjologii i Intensywnej Terapii GUMed

ul. Smoluchowskiego 17, 80–214 Gdańsk, Poland


Author statement

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).

  2. The submission file is in OpenOffice, Microsoft Word or RTF document file format.

  3. Where available, URLs for the references have been provided.

  4. The text is written using font size 12 and 1.5 space between the lines; employs italics, rather than underlining (except with URL addresses); all illustrations, figures, and tables are included in the text where appropriate or attached in separate file(s).

  5. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which could be found in “About” section.

  6. If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, Świętokrzyska 73 St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: